Acical Jr. Chewable Tablet 250 mg

Acical Jr. Chewable Tablet, manufactured by ACI Limited, is a calcium supplement containing 250 mg Calcium Carbonate per Chewable Tablet. Priced at ৳3.01 per unit, it offers an affordable solution for calcium deficiency. The tablet neutralizes stomach acid, treats hyperacidity, and manages conditions like osteoporosis, renal failure-related hyperphosphatemia, and pregnancy-related calcium needs.

This medication is prescribed for hypoparathyroidism, chronic diarrhea, vitamin D deficiency, and acid indigestion. It binds dietary phosphate in renal patients, reducing aluminum-based drug dependency. Recommended doses vary: 540-2000 mg/day for adults as an antacid, and 2.5-9.0 gm/day for renal cases. Always consume with meals for optimal phosphate control.

Common side effects include constipation and gastrointestinal irritation. Hypercalcemia risks rise in renal impairment. Avoid combining with digoxin or tetracyclines without medical consultation. Safe for pregnant/lactating women at prescribed doses. Store in cool, dry conditions to maintain efficacy.

LSI Keywords like Acical Jr. Chewable Tablet uses, dosage rules, and side effects are critical for patient education. Related brand Acical 500 mg offers higher strength, while ACI Limited ensures quality compliance. For detailed pharmacologic data, explore our Calcium Carbonate resource.

Adults: 1-4 tablets (250/500 mg) daily (540-2000 mg). Children: Half adult dose. Pregnancy: 1200-1500 mg calcium/day. Renal patients: 2.5-9 gm/day with meals. 1000 mg tablet: 2-3 tablets as needed, repeat hourly if required.

Orally administered Acical Jr. may be irritating to the GI tract. It may also cause constipation. Hypercalcaemia is rarely produced by administration of calcium alone, but may occur when large doses are given to patients with chronic renal failure.

Pregnancy Category A (Safe). Compatible with lactation. Use under medical supervision for dose optimization.

Monitor serum calcium-phosphate levels during prolonged use. Renal patients require creatinine checks. Avoid excessive self-medication.

Pediatric: Clinically validated. Elderly: Constipation risk. Renal impairment: Dose adjustment needed. Hepatic: No specific restrictions.